사이언스 바이오메디컬PBM 주가

12 Health Care Stocks Moving In Tuesday's Intraday Session

Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing

NEW YORK - Psyence BioMed Ltd. , a biopharmaceutical company focused on the development and supply of nature - derived psychedelic compounds for clinical research and therapeutic applications, today...

Psyence BioMed Establishes Active Ibogaine Operations, Production Capabilities In Africa

Psyence BioMed Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company focused on the development and supply of nature-derived psychedelic compounds for clinical research and therapeutic

12 Health Care Stocks Moving In Wednesday's After-Market Session

Prestige Consumer Healthcare Announces agreement To Acquire LaCorium Health, A Leader In Australian Therapeutic Skin Care For ~150M

LaCorium AcquisitionThe Company today is also announcing a definitive agreement to acquire LaCorium Health ("LaCorium"), for approximately $150 million in cash. The transaction, subject to customary conditions, is

[6-K] 6-K — REPORT OF FOREIGN PRIVATE ISSUER

[6-K] 6-K — REPORT OF FOREIGN PRIVATE ISSUER

[6-K] 6-K — REPORT OF FOREIGN PRIVATE ISSUER

[6-K] 6-K — REPORT OF FOREIGN PRIVATE ISSUER

[6-K] 6-K — REPORT OF FOREIGN PRIVATE ISSUER